AD's p-tau217 Results and the Road Ahead for Parkinson's PET tracers

These seem like really great suggestions! I agree that it is much easier to think about these studies as “federated” instead of fully integrated, in which case identifying some reference participants who are scanned with all tracers provides the comparators across studies. And the depth and breadth of PPMI makes it the ideal candidate to provide those comparator participants. Here’s hoping that we can influence future studies in this direction!